Can we predict who will lose their sight? new study aims to find out

NCT ID NCT07653269

Recruiting now Knowledge-focused Sponsor: Singapore National Eye Centre Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is following 1,500 adults aged 55 and older to learn how early age-related macular degeneration (AMD) turns into the advanced form that can cause vision loss. Researchers will use eye imaging, genetic tests, and other measurements to find clues that predict progression. The goal is to create personalized monitoring plans for those at highest risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to personalized monitoring plans for people at risk of vision loss from AMD, helping catch progression earlier.
What could go wrong: This is an observational study, not a treatment trial. It will not directly prevent or cure AMD, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Locations

Outram Community Hospital
RECRUITING

Singapore, Singapore
Singapore National Eye Centre/ Singapore Eye Research Institute
RECRUITING

Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.